|

NIO752 Clinical Trials

1 actively recruiting trial across 1 location

▼ -1 trial since June 2026

Pipeline

Phase 1: 1

Top Sponsors

  • University College, London1

Indications

  • Autosomal Dominant Alzheimer Disease Due to Mutation of Amyloid Precursor Protein (Disorder)1
  • Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 2 (Disorder)1
  • Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 1 (Disorder)1
  • Alzheimer's Disease1
  • Alzheimer Disease1

St Louis, Missouri1 trial

A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK

Washington University in St. Louis

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.